Treatment of Fas agonist failed to promote cancer cell death in highly expressed cFLIP lymphoma (Karpas 299 and SU-DHL1), which could be sensitized by using cFLIP RNA interference [53]. The gene discussed is CFLAR; the disease is lymphoma.